According to a new report from Intel Market Research, the global Empagliflozin Drug market was valued at USD 20,500 million in 2025 and is projected to reach USD 91,000 million by 2034, growing at an exceptional CAGR of 18% during the forecast period (2026–2034). This remarkable expansion is driven by rising global diabetes prevalence, expanded cardiovascular and renal indications, and...